Core Viewpoint - Yara International ASA (YARIY) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Revisions - The Zacks Consensus Estimate for Yara International ASA indicates expected earnings of $2.36 per share for the fiscal year ending December 2026, showing no year-over-year change [9]. - Over the past three months, analysts have raised their earnings estimates for Yara International ASA by 30.4% [9]. Zacks Rating System - The Zacks rating system is based solely on changes in a company's earnings picture, making it a reliable tool for investors to gauge stock performance [2][3]. - The system classifies stocks into five groups, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions [10][11]. Market Implications - The upgrade to Zacks Rank 1 for Yara International ASA suggests that the stock may experience upward price movement due to improved earnings outlook and potential buying pressure from investors [4][6].

Core Viewpoint - Avita Medical Inc. (RCEL) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional investors to buy or sell, which subsequently affects stock prices [4]. Business Outlook - The upgrade in Zacks Rank for Avita Medical suggests an improvement in the company's underlying business, which could lead to an appreciation in stock value as investors respond positively to this trend [5][10]. - For the fiscal year ending December 2026, Avita Medical is expected to earn -$0.97 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 12.2% over the past three months, indicating a positive revision trend [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have generated an average annual return of +25% since 1988 [7]. - The upgrade of Avita Medical to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Brookdale Senior Living (BKD) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][2]. Earnings Estimates and Stock Price Movement - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements [3][5]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [3]. Business Improvement Indicators - The upgrade in earnings estimates for Brookdale suggests an improvement in the company's underlying business, which could lead to an increase in stock price as investors respond positively [4][9]. - Over the past three months, the Zacks Consensus Estimate for Brookdale has increased by 25%, indicating a positive revision trend [7]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [6][8]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, positioning Brookdale among the best candidates for potential market-beating returns [9].

Investors might want to bet on Iamgold (IAG) , as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.A company's changing earnings picture is at the core of the Zacks rating. The system tracks the Zacks Consensus Estimate -- the consensus measure of EPS estimates from the sell-side analysts covering the stock -- for the current and following years.Since a changing earnings ...

Core Viewpoint - Bausch + Lomb (BLCO) has received an upgrade to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Performance - The Zacks rating system is based on changes in earnings estimates, which are closely correlated with stock price movements [4][6]. - For Bausch + Lomb, the recent upgrade reflects an improvement in the company's underlying business, likely leading to increased stock prices due to investor confidence [5][10]. Earnings Estimate Revisions - For the fiscal year ending December 2026, Bausch + Lomb is expected to earn $0.80 per share, unchanged from the previous year, but the Zacks Consensus Estimate has increased by 1.8% over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks, which have averaged a +25% annual return since 1988 [7][9]. - Bausch + Lomb's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, suggesting a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Heineken NV has been upgraded to a Zacks Rank 2 (Buy), indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system reflects changes in earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, leading to price movements based on their buying or selling activities [4]. Business Outlook - The upgrade in Heineken's rating suggests an improvement in the company's underlying business, which could lead to an increase in stock price as investors respond positively [5][10]. - For the fiscal year ending December 2026, Heineken is expected to earn $3.19 per share, with a 5.5% increase in the Zacks Consensus Estimate over the past three months [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly for Zacks Rank 1 stocks which have averaged a +25% annual return since 1988 [7][9]. - Heineken's upgrade to Zacks Rank 2 places it in the top 20% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10].

Core Viewpoint - Redwood Trust (RWT) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system emphasizes the importance of earnings estimate revisions, which have shown a strong correlation with near-term stock price movements [4][6]. - An increase in earnings estimates typically leads to higher fair value calculations by institutional investors, resulting in stock price movements [4]. Recent Performance and Projections - Redwood Trust is projected to earn $1.28 per share for the fiscal year ending December 2026, with no year-over-year change expected [8]. - Over the past three months, the Zacks Consensus Estimate for Redwood Trust has increased by 37.6%, reflecting a positive trend in earnings estimates [8]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a "Strong Buy" rating, indicating superior earnings estimate revisions and potential for market-beating returns [10].

Core Viewpoint - NN Group NV Unsponsored ADR (NNGRY) has received a Zacks Rank 1 (Strong Buy) upgrade, indicating a positive trend in earnings estimates which is a significant factor influencing stock prices [1][4]. Earnings Estimates and Ratings - The Zacks rating system is primarily based on changes in a company's earnings outlook, with the Zacks Consensus Estimate reflecting EPS estimates from sell-side analysts [2]. - The recent upgrade for NN Group suggests an improved earnings outlook, which is likely to positively affect its stock price [4][6]. Impact of Earnings Revisions - Changes in future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements [5]. - Institutional investors utilize earnings estimates to determine the fair value of stocks, and their trading activities based on these estimates can lead to significant price movements [5]. Performance of Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - The upgrade of NN Group to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [11]. Earnings Estimate for NN Group - NN Group is projected to earn $4.81 per share for the fiscal year ending December 2026, with no year-over-year change, while the Zacks Consensus Estimate has increased by 6.7% over the past three months [9].

分组1 - IdaCorp reported quarterly earnings of $0.78 per share, exceeding the Zacks Consensus Estimate of $0.74 per share, and showing an increase from $0.70 per share a year ago, resulting in an earnings surprise of +5.88% [1] - The company posted revenues of $405.24 million for the quarter ended December 2025, which was 2.85% below the Zacks Consensus Estimate, and an increase from $398.13 million year-over-year [2] - IdaCorp has surpassed consensus EPS estimates three times over the last four quarters, but has not beaten revenue estimates during the same period [2] 分组2 - The stock has gained approximately 12% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.13 on revenues of $462.34 million, and for the current fiscal year, it is $6.42 on revenues of $1.94 billion [7] - The Utility - Electric Power industry, to which IdaCorp belongs, is currently ranked in the top 36% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Core Viewpoint - Salesforce (CRM) has experienced significant selling pressure, resulting in a 15.3% decline in stock price over the past four weeks, but analysts anticipate better-than-expected earnings in the near future [1] Group 1: Technical Analysis - The Relative Strength Index (RSI) is utilized to determine if a stock is oversold, with a reading below 30 indicating oversold conditions [2] - CRM's current RSI reading is 29.64, suggesting that the heavy selling may be exhausting itself and a trend reversal could be imminent [5] - RSI serves as a momentum oscillator that helps identify potential price reversals, indicating that investors may seek entry points for a rebound [3] Group 2: Fundamental Analysis - Analysts have raised earnings estimates for CRM, leading to a 0% increase in the consensus EPS estimate over the last 30 days, which typically correlates with price appreciation [7] - CRM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8]